Pakarinen, "Effects of Convulsant Agents on Learning and Memory in Squirrel Monkeys," Dissertation Abstracts International, 54(01B), 189 (Mar. 31, 1993-13 entered in the Louisiana State University online catalog). |
Calderon et al., "Synthesis and Absolute Configuration of Optically Pure Enantiomers of (.+-.)-BW373U86, A Nonpeptidic.delta.-Opioid Receptor Agonist," College on Problems of Drug Dependence, Inc., Fifty-fifth Annual Scientific Meeting, Toronto, Canada, Poster Presentation, (Jun. 12-17, 1993). |
Selley, "BW373U86 A Non-peptide .delta.-Opioid Agonist With Novel Receptor-G-Protein-Mediated Actions," Meeting of the International Narcotics Research Conference (INRC). Skoevde, Sweden, Abstract (Jul. 11-16, 1993). |
Comer, "BW373U86: Behavioral Pharmacology of a Putative Non-Peptide, Systemically-Active Delta Opioid Agonist," Dissertation Abstracts International, 53(5b). 2578 (Jul. 1, 1992--entered in the University of Michigan online catalog). |
Chang, "Identification of a Novel, Potent and Selective Non-Peptidic Delta-selective Agonist BW373U86," Meeting of the International Narcotics Research Conference (INRC). Keystone, Colorado, Oral Presentation, (Jun. 23-27, 1992). |
Comer, "BW373U86: Delta-receptor-mediation of Convulsions and Refractoriness," Meeting of the International Narcotics Research Conference (INRC). Keystone, Colorado, Oral Presentation, (Jun. 23-27, 1992). |
Dykstra, "Behavioral Effects of a Novel and Selective Opioid Delta Agonist in the Monkey," Meeting of the International Narcotics Research Conference (INRC). Keystone, Colorado, Oral Presentation, (Jun. 23-27, 1992). |
Porreca, "Multiple Opioid Delta Receptors," Meeting of the International Narcotics Research Conference (INRC), Keystone, Colorado, Oral Presentation, (Jun. 23-27, 1992). |
Boradbent et al., "Role of Opioid Receptor Subtypes in the Discriminative Stinulus Effects of Cocaine," Meeting of the International Narcotics Research Conference (INRC), Keystone, Colorado, Abastact, (Jun. 23-27, 1992). |
Dworkin et al., "Effects of .delta.-Opiate Agonist and Antagonists on Cocaine and Heroin Self Administration in Rats," Meeting of the International Narcotics Research conference (INRC). Keystone, Colorado, Abstract (Jun. 23-27, 1992). |
Dykstra, et al., "Effects of a Novel Delta Opioid Agonsit in Squirrel Monkeys Responding Under a Schedule of Shock Tritration." Meeting of the International Narcotics Research Conference (INRC), Keystone, Colorado, Abstract (Jun. 23-27, 1992). |
Lee et al., "A Non-peptide Delta-Opioid Receptor Agonist BW373U86 Suppresses Naloxone-precipated Morphine Abstience," Meeting of the International Narcotics Research Conference (INRC), Keystone, Colorado, Abstract (Jun. 23-27, 1992). |
Porreca et al., "Pharmacology of Multiple Opioid Delta Receptors," National Institute on Drug Abuse Research Monograph Series 132, Problems of Drug Dependence, 1992: Proceeding of the 54th Annual Scientific Meeting, 430-436 (1993). |
Iwamoto et al., "Calcium Antagonism, by KB-2796, a New Diphenylpiperazine Analogue, in Dog Vascular Smooth Muscle." J. Pharm. Pharmacol., 43, 535-539 (1991). |
Goenechea et al., "Untersuchungen zur Biotransformation von Meclozin im Menschlichen Korper," J. Clin. Chem. Clin. Biochem., 26, 105-115 (1988)--See Specification, p. 4, last paragraph and Chemical Abstracts 108: 215746g. |
Iwamoto et al., "Effects of KB-2796, a New Calcium Antagonist, and Other Diphenylpiperazines on �.sup.3 H!Nitrendipine Binding," Japan J. Pharmacol. 48, 241-247 (1988). |
Natsuka et al., "Synthesis and Structure-Activity Relationships of 1-Substituted 4-(1,2-Diphenylethyl)piperazine Derivatives having Narcotic Agonist and Antagonist Activity," J. Med. Chem., 30(10), 1779-1787 (1987). |
Meuldermas et al., "Plasma Levels, Biotransformation and Excretion of Oxatomide (R 35 443) in Rats, Dogs and Man," Xenobiotica, 14(6), 445-462 (1984). |
Krishnamurthy, "A Highly Efficient and General N-Monomethylation of Functionalized Primary Amines Via Formylation-Borane: Methyl Sulfide Reduction," Tet. Let., 23(33), 3315-3318 (1982). |
Lord et al., "Endogenous Opioid Peptides: Multiple Agonists and Receptors,"Nature, 267, 495-499 (1977). |
Chang et al., "A Novel, Potent and Selective Nonpeptidic Delta Opioid Receptor Agonist BW 373U86", J. Pharmacol. Exp. Ther., 267, 852-857 (1993). |
Childers et al., "BW373U86: A Non-peptidic .delta.-Opioid Agonist With Novel Receptor-g Protein-mediated Actions in Rat Brain Membranes and Neuroblastoma Cells", Molec. Pharmacol., 44,827-834 (1993). |
Comer et al., "Convulsive Effects of Systemic Administration of the Delta Opioid Agonist BW373U86 in Mice", J. Pharmacol. Exp. Ther., 267,888-895 (1993). |
Comer et al., "Discriminative Stimulus Effects of BW373U86: A Non-peptide Ligand With Selectivity for Delta Opioid Receptors", J. Pharmacol. Exp. Ther., 267, 866-874 (1993). |
Dykstra et al., "A Novel Delta Opioid Agonist, BW373U86, in Squirrel Monkeys Responding Under a Schedule of Shock Titration", J. Pharmacol. Exp. Ther., 267, 875-882 (1993). |
Lee et al., "A Nonpeptidic Delta-opioid Receptor Agonist, BW373U86, Attenuates the Development and Expression of Morphine Abstinence Precipitated by Naloxone in Rat . . .", J. Pharmacol. Exp. Ther., 267, 883-887 (1993). |
Negus et al., "Effects of Opioid Agonists Selective for Mu, Kappa and Delta Opioid Receptors on Schedule-controlled Responding in Rhesus Monkeys: Antagonism by Quadazocine", J. Pharmacol. Exp. Ther., 267, 896-903 (1993). |
Wild et al., "Binding of 373U86, A Non-peptidic .delta.-Opioid Receptor Agonist, is Not Regulated by Guanine Nucleotides and Sodium", Eur. J. Pharmacol.-Molec. Pharmacol., Section 246, 289-292 (1993). |
Wild et al., "Antiociceptive Actions of BW373U86 in the Mouse", J. Pharmacol, Exp. Ther. 267, 858-865, 1993. |
Xu et al., "Differential Binding of Opioid Peptides and Other Drugs to Two Subtypes of Opioid.delta..sub.ncx Binding Sites in Mouse Brain: Further Evidence of .delta. Receptor Heterogeneity", Peptides 14, 893-907 (1993). |